“The Bullpen provided an incredibly helpful process of intentionality, expert feedback, and practice in preparing our investor pitch for JPM. It was a great investment of our resources in advance of this important opportunity and no question it made us better prepared to take maximum advantage of our time on the ground at JPM.”

Mark Platt, CEO at Makana Therapeutics.

Mark Platt

Tibor Zechmeister, Managing Partner CommuModo GmbH

“The Bullpen was an extraordinary series of talks, workshops and events to improve our overall preparedness for our Us market entry. The final program during the JPM conference in San Francisco in January 2023 made it possible to connect and network with top class CEOs and healthtech, biotech experts. I can recommend this event without any hesitation.”

Anna ArgoAnna Argo, Director of Business Development, Cytotheryx

“The Bullpen was a great experience! It was beneficial to establish relationships with other Bullpen members ahead of JPM which accelerated conversations and collaboration opportunities once we met in person at the event.”

Since 1984, when I presented the Diasonics story at JPM, the Bullpen has been the most impactful meeting I attended. The contacts made during the Bullpen meetings were outstanding. Thank you Christiaan, Paula and a very effective team.”

Ron Schilling

Executive Chairman EchoPixel Technology

“Bullpen offers me a community of expertise, connection, and coaching that would have been impossible to assemble on my own. Christiaan and team have helped me grow as a Founder, and my business has grown as a result.”

Rob Blatt,

CEO, envoyatHome.

“The Bullpen is an excellent resource for early-stage scientists or entrepreneurs to prepare for the JP Morgan conference. The short program provides insights into conference activities, provides a deeper understanding of “on the ground” expectations and access to practical feedback from investors and fellow entrepreneurs. From a personal standpoint, the network creates a sense of belonging as well as provides each entrepreneur points of reference as it relates to “what is success” from the conference,”

Lu Alleruzo CEO Immunophotonics, Inc.
Lu Alleruzo, CEO Immunophotonics, Inc
Bullpen Logo

Gathering life science investors and CxOs with a shared goal of helping each other.

Join an exclusive community of top-tier life science deal makers.

Questions? Contact Us Here


Bullpen Logo Square